<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36645453</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2023</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>Epidemiology, Symptomatology, and Risk Factors for Long COVID Symptoms: Population-Based, Multicenter Study.</ArticleTitle><Pagination><StartPage>e42315</StartPage><MedlinePgn>e42315</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e42315</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/42315</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long COVID induces a substantial global burden of disease. The pathogenesis, complications, and epidemiological and clinical characteristics of patients with COVID-19 in the acute phase have been evaluated, while few studies have characterized the epidemiology, symptomatology, and risk factors of long COVID symptoms. Its characteristics among patients with COVID-19 in the general population remain unaddressed.</AbstractText><AbstractText Label="OBJECTIVE">We examined the prevalence of long COVID symptoms, its symptom patterns, and its risk factors in 4 major Chinese cities in order to fill the knowledge gap.</AbstractText><AbstractText Label="METHODS">We performed a population-based, multicenter survey using a representative sampling strategy via the Qualtrics platform in Beijing, Shanghai, Guangzhou, and Hong Kong in June 2022. We included 2712 community-dwelling patients with COVID-19 and measured the prevalence of long COVID symptoms defined by the World Health Organization (WHO), and their risk factors. The primary outcomes were the symptoms of long COVID, with various levels of impact. A descriptive analysis of the prevalence and distribution of long COVID symptoms according to disease severity was conducted. A sensitivity analysis of increasing the number of long COVID symptoms was also conducted. Univariate and multivariate regression analyses were performed to examine the risk factors of severe long COVID symptoms, including age, gender, marital status, current occupation, educational level, living status, smoking habits, monthly household income, self-perceived health status, the presence of chronic diseases, the use of chronic medication, COVID-19 vaccination status, and the severity of COVID-19.</AbstractText><AbstractText Label="RESULTS">The response rate was 63.6% (n=2712). The prevalence of long COVID, moderate or severe long COVID, and severe long COVID was 90.4% (n=2452), 62.4% (n=1692), and 31.0% (n=841), respectively. Fatigue (n=914, 33.7%), cough (n=865, 31.9%), sore throat (n=841, 31.0%), difficulty in concentrating (n=828, 30.5%), feeling of anxiety (n=817, 30.2%), myalgia (n=811, 29.9%), and arthralgia (n=811, 29.9%) were the most common severe long COVID symptoms. From multivariate regression analysis, female gender (adjusted odds ratio [aOR]=1.49, 95% CI 1.13-1.95); engagement in transportation, logistics, or the discipline workforce (aOR=2.52, 95% CI 1.58-4.03); living with domestic workers (aOR=2.37, 95% CI 1.39-4.03); smoking (aOR=1.55, 95% CI 1.17-2.05); poor or very poor self-perceived health status (aOR=15.4, 95% CI 7.88-30.00); &#x2265;3 chronic diseases (aOR=2.71, 95% CI 1.54-4.79); chronic medication use (aOR=4.38, 95% CI 1.66-11.53); and critical severity of COVID-19 (aOR=1.52, 95% CI 1.07-2.15) were associated with severe long COVID. Prior vaccination with &#x2265;2 doses of COVID-19 vaccines was a protective factor (aOR=0.35-0.22, 95% CI 0.08-0.90).</AbstractText><AbstractText Label="CONCLUSIONS">We examined the prevalence of long COVID symptoms in 4 Chinese cities according to the severity of COVID-19. We also evaluated the pattern of long COVID symptoms and their risk factors. These findings may inform early identification of patients with COVID-19 at risk of long COVID and planning of rehabilitative services.</AbstractText><CopyrightInformation>&#xa9;Martin Chi-Sang Wong, Junjie Huang, Yuet-Yan Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, Rachel Ngan-Yin Chan, Steven Wai-Ho Chau, Siew-Chien Ng, Yun-Kwok Wing, Francis Ka-Leung Chan. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 07.03.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wong</LastName><ForeName>Martin Chi-Sang</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-7706-9370</Identifier><AffiliationInfo><Affiliation>Jockey Club School of Public Health &amp; Primary Care, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Health Education and Health Promotion, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, The Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Junjie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2382-4443</Identifier><AffiliationInfo><Affiliation>Jockey Club School of Public Health &amp; Primary Care, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Health Education and Health Promotion, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Yuet-Yan</ForeName><Initials>YY</Initials><Identifier Source="ORCID">0000-0001-5012-0041</Identifier><AffiliationInfo><Affiliation>Jockey Club School of Public Health &amp; Primary Care, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Grace Lai-Hung</ForeName><Initials>GL</Initials><Identifier Source="ORCID">0000-0002-2863-9389</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Data Analytics Centre, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Terry Cheuk-Fung</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0002-1819-2464</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Data Analytics Centre, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Rachel Ngan-Yin</ForeName><Initials>RN</Initials><Identifier Source="ORCID">0000-0002-3009-3565</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Tai Po, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chau</LastName><ForeName>Steven Wai-Ho</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0002-2986-8677</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Tai Po, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Siew-Chien</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-6850-4454</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wing</LastName><ForeName>Yun-Kwok</ForeName><Initials>YK</Initials><Identifier Source="ORCID">0000-0002-5745-5474</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Tai Po, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Francis Ka-Leung</ForeName><Initials>FK</Initials><Identifier Source="ORCID">0000-0001-7388-2436</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">general population</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">multicenter survey</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">symptom</Keyword></KeywordList><CoiStatement>Conflicts of Interest: S-CN and FK-LC are scientific cofounders of Geniebiome Ltd.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>16</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36645453</ArticleId><ArticleId IdType="pmc">PMC9994465</ArticleId><ArticleId IdType="doi">10.2196/42315</ArticleId><ArticleId IdType="pii">v9i1e42315</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO coronavirus (COVID-19) dashboard. World Health Organization.  [2022-07-09].  
 https://covid19.who.int/
</Citation></Reference><Reference><Citation>How long does COVID-19 last? Kings College, London, 2020. ZOE Limited.  [2023-02-23].  
 https://covid19.joinzoe.com/post/covid-long-term?fbclid=IwAR1RxIcmmdL-EFjh_aI-
</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z. 
 
10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8. 
 
S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Post COVID-19 condition (long COVID) World Health Organization.  [2023-02-23].  
 https://www.who.int/srilanka/news/detail/16-10-2021-post-covid-19-condition
.</Citation></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, Greenhalgh T. Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services. BMC Health Serv Res. 2020 Dec 20;20(1):1144. doi: 10.1186/s12913-020-06001-y. 
 
10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021 Jul 26;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022 Apr;22(4):e102&#x2013;e107. doi: 10.1016/s1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikuteit M, Heinemann S, Roder S, Niewolik J, Schr&#xf6;der D, Vahldiek K, Klawitter S, Cossmann A, Bergemann T, Degen C, Klawonn F, Behrens GMN, M&#xfc;ller F, Dopfer-Jablonka A, Steffens S. Long-term consequences of COVID-19 and the pandemic: protocol for a web-based, longitudinal observational study (defeat) JMIR Res Protoc. 2022 Oct 26;11(10):e38718. doi: 10.2196/38718. 
 
v11i10e38718</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/38718</ArticleId><ArticleId IdType="pmc">PMC9611102</ArticleId><ArticleId IdType="pubmed">36108134</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021 Oct 22;53(10):737&#x2013;754. doi: 10.1080/23744235.2021.1924397. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021 May;93(5):2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, Zhang F, Li AYL, Lu W, Hui DS, Chan PK, Chan FKL, Ng SC. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022 Mar 26;71(3):544&#x2013;552. doi: 10.1136/gutjnl-2021-325989. 
 
gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline. National Institute for HealthCare Excellence.  [2022-08-13].  
 https://www.nice.org.uk/guidance/ng188
.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, Berlit P, B&#xf6;ing S, Brinkmann F, Franke C, Gl&#xf6;ckl R, Gogoll C, Hummel T, Kronsbein J, Maibaum T, Peters EMJ, Pfeifer M, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Scheibenbogen C, Stallmach A, Stegbauer M, Wagner HO, Waller C, Wirtz H, Zeiher A, Zwick RH. [S1 guideline post-COVID/long-COVID] Pneumologie. 2021 Nov 02;75(11):869&#x2013;900. doi: 10.1055/a-1551-9734. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1551-9734</ArticleId><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M, Go&#xeb;rtz YMJ, Houben-Wilke S, Machado FVC, Meys R, Delbressine JM, Vaes AW, Burtin C, Posthuma R, Franssen FME, Hajian B, Vijlbrief H, Spies Y, van't Hul AJ, Janssen DJA, Spruit MA. Severe fatigue in long COVID: web-based quantitative follow-up study in members of online long COVID support groups. J Med Internet Res. 2021 Sep 21;23(9):e30274. doi: 10.2196/30274. 
 
v23i9e30274</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30274</ArticleId><ArticleId IdType="pmc">PMC8457337</ArticleId><ArticleId IdType="pubmed">34494964</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FV, Houben-Wilke S, Burtin C, Posthuma R, Franssen FM, van Loon N, Hajian B, Spies Y, Vijlbrief H, van't Hul AJ, Janssen DJ, Spruit MA. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020 Oct 10;6(4):00542-2020. doi: 10.1183/23120541.00542-2020. 
 
00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozenfeld Y, Beam J, Maier H, Haggerson W, Boudreau K, Carlson J, Medows R. A model of disparities: risk factors associated with COVID-19 infection. Int J Equity Health. 2020 Jul 29;19(1):126. doi: 10.1186/s12939-020-01242-z. 
 
10.1186/s12939-020-01242-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-020-01242-z</ArticleId><ArticleId IdType="doi">10.1186/s12939-020-01242-z</ArticleId><ArticleId IdType="pmc">PMC7387879</ArticleId><ArticleId IdType="pubmed">32727486</ArticleId></ArticleIdList></Reference><Reference><Citation>Meza-Torres B, Delanerolle G, Okusi C, Mayor N, Anand S, Macartney J, Gatenby P, Glampson B, Chapman M, Curcin V, Mayer E, Joy M, Greenhalgh T, Delaney B, de Lusignan S. Differences in clinical presentation with long COVID after community and hospital infection and associations with all-cause mortality: English Sentinel Network Database Study. JMIR Public Health Surveill. 2022 Aug 16;8(8):e37668. doi: 10.2196/37668. 
 
v8i8e37668</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37668</ArticleId><ArticleId IdType="pmc">PMC9384859</ArticleId><ArticleId IdType="pubmed">35605170</ArticleId></ArticleIdList></Reference><Reference><Citation>Laires PA, Dias S, Gama A, Moniz M, Pedro AR, Soares P, Aguiar P, Nunes C. The association between chronic disease and serious COVID-19 outcomes and its influence on risk perception: survey study and database analysis. JMIR Public Health Surveill. 2021 Jan 12;7(1):e22794. doi: 10.2196/22794. 
 
v7i1e22794</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/22794</ArticleId><ArticleId IdType="pmc">PMC7806339</ArticleId><ArticleId IdType="pubmed">33433397</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanover C, Mizrahi B, Kalkstein N, Marcus K, Akiva P, Barer Y, Shalev V, Chodick G. What factors increase the risk of complications in SARS-CoV-2-infected patients? A cohort study in a nationwide Israeli health organization. JMIR Public Health Surveill. 2020 Aug 25;6(3):e20872. doi: 10.2196/20872. 
 
v6i3e20872</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/20872</ArticleId><ArticleId IdType="pmc">PMC7451109</ArticleId><ArticleId IdType="pubmed">32750009</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020 Aug 25;324(8):782&#x2013;793. doi: 10.1001/jama.2020.12839.2768391</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020 Oct 23;371:m3862. doi: 10.1136/bmj.m3862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3862</ArticleId><ArticleId IdType="pubmed">33097561</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Go&#xeb;rtz YMJ, Van Herck M, Machado FVC, Meys R, Delbressine JM, Houben-Wilke S, Gaffron S, Maier D, Burtin C, Posthuma R, van Loon NPH, Franssen FME, Hajian B, Simons SO, van Boven JFM, Klok FA, Spaetgens B, Pinxt CM, Liu LY, Wesseling G, Spies Y, Vijlbrief H, van't Hul AJ, Janssen DJ, Spruit MA. Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. 2021 Apr 26;7(2):00141-2021. doi: 10.1183/23120541.00141-2021. 
 
00141-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00141-2021</ArticleId><ArticleId IdType="pmc">PMC8012818</ArticleId><ArticleId IdType="pubmed">34041295</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Hirose M, Inoue Y, Kunishima H, Otsubo T, Matsuda T. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID. J Med Virol. 2022 Jul 08;94(7):3416&#x2013;3420. doi: 10.1002/jmv.27689. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Survey methodology and compliance best practices. Qualtrics.  [2022-08-13].  
 https://www.qualtrics.com/support/survey-platform/survey-module/survey-checker/survey-methodology-compliance-best-practices/
</Citation></Reference><Reference><Citation>Hughes SE, Haroon S, Subramanian A, McMullan C, Aiyegbusi OL, Turner GM, Jackson L, Davies EH, Frost C, McNamara G, Price G, Matthews K, Camaradou J, Ormerod J, Walker A, Calvert MJ. Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis. BMJ. 2022 Apr 27;377:e070230. doi: 10.1136/bmj-2022-070230. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070230</ArticleId><ArticleId IdType="pmc">PMC9043395</ArticleId><ArticleId IdType="pubmed">35477524</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization. 2020.  [2022-08-13].  
 https://apps.who.int/iris/handle/10665/332196
.</Citation></Reference><Reference><Citation>Lau LH, Wong SH, Yip TCF, Wong GLH, Wong VWS, Sung JJY. Collateral effect of coronavirus disease 2019 pandemic on hospitalizations and clinical outcomes in gastrointestinal and liver diseases: a territory-wide observational study in Hong Kong. Gastroenterology. 2020 Nov;159(5):1979&#x2013;1981.e3. doi: 10.1053/j.gastro.2020.07.042. 
 
S0016-5085(20)35005-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.07.042</ArticleId><ArticleId IdType="pmc">PMC7382332</ArticleId><ArticleId IdType="pubmed">32721440</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano C, Fehnel S, Stoddard J, Sadoff J, Lewis S, McNulty P, Chan EKH, Evans E, Jamieson C, Slagle AF, Mangel A, McQuarrie K. Development of a novel patient-reported outcome measure to assess signs and symptoms of COVID-19. J Patient Rep Outcomes. 2022 Jul 29;6(1):85. doi: 10.1186/s41687-022-00471-w. doi: 10.1186/s41687-022-00471-w.10.1186/s41687-022-00471-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-022-00471-w</ArticleId><ArticleId IdType="doi">10.1186/s41687-022-00471-w</ArticleId><ArticleId IdType="pmc">PMC9336135</ArticleId><ArticleId IdType="pubmed">35904710</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 risk by occupation and workplace. EMG &#x2013; Transmission Group. 2021. Feb 11,  [2023-02-25].  
 https://tinyurl.com/ytvtardd
.</Citation></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021 Apr;174(4):576&#x2013;578. doi: 10.7326/m20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group  Persistent symptoms in patients after acute COVID-19. JAMA. 2020 Aug 11;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603. 
 
2768351</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. 
 
S2589-5370(21)00299-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020 Dec 08;324(22):2251&#x2013;2252. doi: 10.1001/jama.2020.22717.2773338</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of long COVID symptoms and COVID-19 complications. UK Office for National Statistics. 2020.  [2022-08-13].  
 https://tinyurl.com/ymths8aj
.</Citation></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomed Health Behav. 2020 Jun 25;8(2):61&#x2013;69. doi: 10.1080/21641846.2020.1778227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2020.1778227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Chen R, Charpignon M, Kiang M, Riley A, Glymour M. COVID-19 mortality among working-age Americans in 46 states, by industry and occupation. medRxiv 2022.03.29.2227. 2022 doi: 10.1101/2022.03.29.22273085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.29.22273085</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A. The effect of smoking on COVID-19 severity: a systematic review and meta-analysis. J Med Virol. 2021 Feb 13;93(2):1045&#x2013;1056. doi: 10.1002/jmv.26389. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26389</ArticleId><ArticleId IdType="pmc">PMC7436545</ArticleId><ArticleId IdType="pubmed">32749705</ArticleId></ArticleIdList></Reference><Reference><Citation>Umnuaypornlert A, Kanchanasurakit S, Lucero-Prisno DE, Saokaew S. Smoking and risk of negative outcomes among COVID-19 patients: a systematic review and meta-analysis. Tob Induc Dis. 2021 Feb 4;19(February):09&#x2013;13. doi: 10.18332/tid/132411. 
 
09</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tid/132411</ArticleId><ArticleId IdType="pmc">PMC7857247</ArticleId><ArticleId IdType="pubmed">33551713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MA, Hossain KMA, Saunders K, Uddin Z, Walton LM, Raigangar V, Sakel M, Shafin R, Hossain MS, Kabir MF, Faruqui R, Rana MS, Ahmed MS, Chakrovorty SK, Hossain MA, Jahid IK. Prevalence of long COVID symptoms in Bangladesh: a prospective inception cohort study of COVID-19 survivors. BMJ Glob Health. 2021 Dec 14;6(12):e006838. doi: 10.1136/bmjgh-2021-006838. 
 
bmjgh-2021-006838</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-006838</ArticleId><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="pubmed">34906986</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021 Apr 03;76(4):405&#x2013;407. doi: 10.1136/thoraxjnl-2020-216377. 
 
thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Jorge Cardoso M, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y. 
 
10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, Koch J, Nygren T, Scholz S, Sch&#xf6;nfeld V, Vygen-Bonnet S, Wichmann O, Harder T. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 2021 Aug 27;19(1):212. doi: 10.1186/s12916-021-02058-6. 
 
10.1186/s12916-021-02058-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02058-6</ArticleId><ArticleId IdType="doi">10.1186/s12916-021-02058-6</ArticleId><ArticleId IdType="pmc">PMC8390115</ArticleId><ArticleId IdType="pubmed">34446016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ecks S. Multimorbidity, polyiatrogenesis, and COVID-19. Med Anthropol Q. 2020 Dec 04;34(4):488&#x2013;503. doi: 10.1111/maq.12626. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/maq.12626</ArticleId><ArticleId IdType="pmc">PMC7753613</ArticleId><ArticleId IdType="pubmed">33274530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustos-V&#xe1;zquez E, Padilla-Gonz&#xe1;lez E, Reyes-G&#xf3;mez D, Carmona-Ramos MC, Monroy-Vargas JA, Ben&#xed;tez-Herrera A E, Mel&#xe9;ndez-Mier G. Survival of COVID-19 with multimorbidity patients. Healthcare (Basel) 2021 Oct 22;9(11):1423. doi: 10.3390/healthcare9111423. 
 
healthcare9111423</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9111423</ArticleId><ArticleId IdType="pmc">PMC8617866</ArticleId><ArticleId IdType="pubmed">34828470</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters J, Brink M, Schoon Y, Bleeker-Rovers C, Schers H, van Hees HWH, van Helvoort H, van den Boogaard M, van der Hoeven H, Reijers MH, Prokop M, Vercoulen J, van den Heuvel M. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19) Clin Infect Dis. 2021 Sep 07;73(5):e1089&#x2013;e1098. doi: 10.1093/cid/ciaa1750. 
 
5998118</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, Khunti K, Alwan NA, Walker AS. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022 May 18;377:e069676. doi: 10.1136/bmj-2021-069676. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, Van der Togt V, Hishmeh L, Rossman J. The impact of COVID vaccination on symptoms of long COVID: an international survey of people with lived experience of long COVID. Vaccines (Basel) 2022 Apr 21;10(5):652. doi: 10.3390/vaccines10050652. 
 
vaccines10050652</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050652</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>